1.

Record Nr.

UNINA9910876723903321

Titolo

Community acquired pneumonia : strategies for management / / edited by Antoni Torres and Rosario Menendez

Pubbl/distr/stampa

Chichester, England ; ; Hoboken, NJ, : John Wiley & Sons, c2008

ISBN

0-470-77277-8

1-281-84105-6

9786611841058

0-470-77278-6

Descrizione fisica

1 online resource (287 p.)

Altri autori (Persone)

Torres MartiA (Antoni)

MenendezRosario

Disciplina

616.2/41

616.241

Soggetti

Community-acquired pneumonia

Pneumonia

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

Community-Acquired Pneumonia; Contents; Preface; List of Contributors; 1 Epidemiology of Community-Acquired Pneumonia Outside Hospital; 2 Epidemiology of Adult Hospitalized Community-Acquired Pneumonia; 3 Microbial Aetiology and Antibiotic Resistances in Community-Acquired Pneumonia; 4 Microbiological Diagnosis of Community-Acquired Pneumonia; 5 Empirical Treatment of Community-Acquired Pneumonia: Current Guidelines; 6 Pathogen Directed Antimicrobial Treatment of Pneumonia; 7 General Pharmacological Considerations in Antibiotic Treatment of Community-Acquired Pneumonia

8 β-Lactams in the Therapy of Community-Acquired Pneumonia9 Macrolides and Ketolides; 10 Role of Fluoroquinolones in the Treatment of Community-Acquired Pneumonia; 11 Non-Responding Pneumonia; 12 Influenza and Pneumococcal Vaccination for Prevention of Community-Acquired Pneumonia in Immunocompetent Adults; 13 Adjunctive Therapy in Community-Acquired Pneumonia; Index

Sommario/riassunto

Community-Acquired Pneumonia (CAP) refers to pneumonia acquired



outside of hospitals or extended-care facilities, and is distinct from Nosocomial or hospital-acquired pneumonia, which is a separate disease entity. It is one of the most common respiratory infections and presents one of the major health problems today, with an incidence that ranges from eight to fifty cases per thousand individuals each year. Mortality is still very high and yet the risk factors are very well known. Many of these are related to antibiotic treatment; delay in administration, inadequacy of empiric antibioti